AU3170499A - Fibroblast growth factor mutein compositions and methods of use therefor - Google Patents
Fibroblast growth factor mutein compositions and methods of use thereforInfo
- Publication number
- AU3170499A AU3170499A AU31704/99A AU3170499A AU3170499A AU 3170499 A AU3170499 A AU 3170499A AU 31704/99 A AU31704/99 A AU 31704/99A AU 3170499 A AU3170499 A AU 3170499A AU 3170499 A AU3170499 A AU 3170499A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- growth factor
- fibroblast growth
- use therefor
- factor mutein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000018233 Fibroblast Growth Factor Human genes 0.000 title 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 title 1
- 229940126864 fibroblast growth factor Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6792998A | 1998-04-28 | 1998-04-28 | |
US09067929 | 1998-04-28 | ||
PCT/JP1999/002013 WO1999055861A2 (en) | 1998-04-28 | 1999-04-15 | Fibroblast growth factor mutein compositions and methods of use therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3170499A true AU3170499A (en) | 1999-11-16 |
Family
ID=22079349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU31704/99A Abandoned AU3170499A (en) | 1998-04-28 | 1999-04-15 | Fibroblast growth factor mutein compositions and methods of use therefor |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3170499A (en) |
WO (1) | WO1999055861A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU774958B2 (en) * | 1999-10-02 | 2004-07-15 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Fibroblast growth factor-5 (FGF-5) is a tumor associated T-cell antigen |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4552700A (en) * | 1999-04-19 | 2000-11-02 | Ballermann, Barbara Jutta | Gene therapy |
JP2005507363A (en) * | 2001-02-16 | 2005-03-17 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | Angiogenesis-inhibiting tripeptides, compositions and methods of their use |
JP2005052001A (en) * | 2001-07-05 | 2005-03-03 | Takara Bio Inc | Gene therapeutic agent |
CN1302109C (en) * | 2004-04-21 | 2007-02-28 | 中国人民解放军军事医学科学院基础医学研究所 | Horny cell growth factor mutant and its preparation method and use thereof |
JP5767314B2 (en) | 2010-04-16 | 2015-08-19 | ソーク インスティチュート フォー バイオロジカル スタディーズ | Methods for treating metabolic disorders using FGF |
CN102477093B (en) * | 2010-11-22 | 2014-03-12 | 中国人民解放军军事医学科学院基础医学研究所 | Preparation method of thermal-stable human keratinocyte growth factor mutant and application of preparation method |
US11103553B2 (en) | 2013-09-25 | 2021-08-31 | Trefoil Therapeutics, Inc. | Modified fibroblast growth factors for the treatment of ocular disorders |
WO2015061331A1 (en) | 2013-10-21 | 2015-04-30 | Salk Institute For Biological Studies | Chimeric fibroblast growth factor (fgf) 2/fgf1 peptides and methods of use |
WO2017127493A1 (en) * | 2016-01-22 | 2017-07-27 | Salk Institute For Biological Studies | Fgf2 truncations and mutants and uses thereof |
KR102440312B1 (en) * | 2020-08-28 | 2022-09-05 | 한국해양과학기술원 | Thermally stable fgf7 polypeptide and use of the same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989000198A1 (en) * | 1987-07-07 | 1989-01-12 | Biotechnology Research Associates, J.V. | Recombinant fibroblast growth factors |
WO1989004832A1 (en) * | 1987-11-24 | 1989-06-01 | Amgen Inc. | Analogs of fibroblast growth factor |
JP3039802B2 (en) * | 1989-07-06 | 2000-05-08 | ザ リージェンツ オブザ ユニバーシティ オブ カリフォルニア | Receptor for fibroblast growth factor |
TW275068B (en) * | 1993-09-24 | 1996-05-01 | American Cyanamid Co | |
EP0730651B1 (en) * | 1993-09-24 | 2005-07-06 | Wyeth Holdings Corporation | Surface loop structural analogues of fibroblast growth factors |
-
1999
- 1999-04-15 AU AU31704/99A patent/AU3170499A/en not_active Abandoned
- 1999-04-15 WO PCT/JP1999/002013 patent/WO1999055861A2/en active Application Filing
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU774958B2 (en) * | 1999-10-02 | 2004-07-15 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Fibroblast growth factor-5 (FGF-5) is a tumor associated T-cell antigen |
Also Published As
Publication number | Publication date |
---|---|
WO1999055861A3 (en) | 2000-04-20 |
WO1999055861A2 (en) | 1999-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2886399A (en) | Intraluminal shunt and methods of use | |
AU2609901A (en) | Antimicrobial compositions and methods of use | |
AU5520998A (en) | Reduction of hair growth | |
AU3599597A (en) | Reduction of hair growth | |
AU1532297A (en) | Starch-emulsifier composition and methods of making | |
AU6298894A (en) | Compositions and methods for promoting hair growth | |
AU9319798A (en) | Reduction of hair growth | |
AU2655097A (en) | Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents | |
AU5730298A (en) | Reduction of hair growth | |
AU3494397A (en) | Fibroblast growth factor receptor activating gene i and related compositions and methods | |
AU5282200A (en) | Methods of reducing factor viii clearance and compositions therefor | |
AU5800399A (en) | Polish composition and method of use | |
AU4215399A (en) | Dermatological compositions and methods | |
AU1403501A (en) | Novel composition and use | |
AU3170499A (en) | Fibroblast growth factor mutein compositions and methods of use therefor | |
AU2111399A (en) | Wear reducing compositions and methods for their use | |
AU1903799A (en) | Compositions and methods for modulating the activity of fibroblast growth factor | |
EP1248844B8 (en) | Analogs of human basic fibroblast growth factor | |
AU1152601A (en) | Compositions and their use | |
AU1522400A (en) | Substituted pyrimidine compositions and methods of use | |
AU5914299A (en) | Antagonists of fibroblast growth factor | |
AU6412599A (en) | Oxybutynin formulations and methods of use | |
AU1856297A (en) | Lyst1 and lyst2 gene compositions and methods of use | |
AU4839100A (en) | Methods of using and compositions comprising n-desmethylzolpidem | |
AU1350699A (en) | Compositions and methods for modulating the activity of fibroblast growth factor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |